Skip to contentC
cbdMD, Inc.
C
YCBDcbdMD, Inc. Q3 2022 · 10-Q
Revenue$8.59M$8.59M−18.6% vs Q3 2021 Net Income-$31.63M-$31.63MN/M vs Q3 2021 EPS Diluted-$24.81-$24.81N/M vs Q3 2021 Gross Profit$5,932,708−17.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
cbdMD, Inc. · CIK 1644903 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,370,932N/M Free Cash Flowderived-$2,459,358N/M Margins · derivedGross margin69.0%+1.0 pt vs Q3 2021
Operating margin-385.5%−322.3 pt vs Q3 2021
Net margin-368.1%−382.7 pt vs Q3 2021
ended Jun 30, 2022 · filed Aug 11, 2022 · 42 d after period end